MCTs, Lauric Acid & the Saturated Fat Debate
How coconut oil's medium-chain triglycerides are metabolized differently, why lauric acid is antimicrobial, and what the science says about saturated fat and heart health.
Coconut oil is roughly 65% medium-chain triglycerides (MCTs) — fats that are metabolized fundamentally differently from the long-chain fats found in most other foods. Instead of being packaged into chylomicrons and circulated through the lymphatic system, MCTs travel directly to the liver via the portal vein, where they're rapidly converted to ketones and used for energy [2]. This makes coconut oil an unusually fast fuel source. Its primary fatty acid, lauric acid (~50% of coconut oil), has potent antimicrobial properties — it disrupts the lipid membranes of bacteria, viruses, and fungi [3]. The saturated fat debate around coconut oil is real, but the evidence is more nuanced than the headlines suggest [4].
Medium-chain triglycerides: a different kind of fat
Most dietary fats are long-chain triglycerides (LCTs) with 14–22 carbon atoms. MCTs have 6–12 carbons, and this size difference changes everything about how they're processed. LCTs require bile salts for emulsification, pancreatic lipase for digestion, and are reassembled into chylomicrons for slow transport through the lymphatic system before reaching the bloodstream. MCTs skip all of this — they're absorbed directly into the portal circulation and delivered to the liver within minutes, where they're preferentially oxidized for energy or converted to ketone bodies (beta-hydroxybutyrate and acetoacetate) [2].
This rapid conversion to ketones is why coconut oil and concentrated MCT oil have become popular in ketogenic diets — they can raise blood ketone levels even in people who aren't fully restricting carbohydrates. The ketogenic effect is strongest with the shorter-chain MCTs (C8 caprylic acid and C10 capric acid). Lauric acid (C12), while technically classified as an MCT by chain length, behaves somewhat like a hybrid — a significant portion is processed through the chylomicron pathway like an LCT [2]. This is an important nuance: pure MCT oil (C8/C10) raises ketones more efficiently than coconut oil.
Lauric acid: antimicrobial fatty acid
Lauric acid makes up approximately 50% of coconut oil's fatty acid profile, and its antimicrobial mechanism is well-documented. When lauric acid is converted to monolaurin in the body, it disrupts the lipid bilayer membranes of enveloped viruses, bacteria, and fungi — essentially dissolving their protective coating [3]. In vitro studies have demonstrated activity against Candida albicans, Staphylococcus aureus, Helicobacter pylori, and several enveloped viruses including measles and HIV.
Ogbolu et al. found that coconut oil was active against all Candida species tested at concentrations of 25–100%, with Candida albicans showing the highest susceptibility [3]. While in vitro results don't directly translate to clinical outcomes (the concentrations used are higher than what dietary consumption delivers to any single tissue), the antimicrobial properties of lauric acid are not disputed. This is also the mechanism behind oil pulling — swishing coconut oil in the mouth for 15–20 minutes to reduce oral bacteria (covered in detail on the Oil Pulling page).
The saturated fat debate
Coconut oil is ~82% saturated fat, which triggered the American Heart Association's 2017 advisory recommending against its use. But the evidence on coconut oil specifically is more complex than the blanket "saturated fat raises LDL" narrative [4].
Key findings from the research:
- HDL response: Most studies show coconut oil raises HDL (the protective lipoprotein) more than it raises LDL, improving or maintaining the total cholesterol/HDL ratio — a metric many researchers consider more predictive of cardiovascular risk than LDL alone [1][4].
- Not all saturated fats are equal: Lauric acid (C12) has a different metabolic pathway than palmitic acid (C16, dominant in red meat and dairy fat). Lumping all saturated fats together ignores meaningful biochemical differences.
- The Assunção trial: A randomized trial comparing coconut oil to soybean oil in women with abdominal obesity found that the coconut oil group had higher HDL and a lower LDL/HDL ratio than the soybean oil group after 12 weeks, while neither group saw an increase in total cholesterol [1].
That said, coconut oil does raise LDL compared to unsaturated oils like olive oil. The practical takeaway: coconut oil is likely a better cooking fat than seed oils (soybean, canola, corn) based on oxidative stability and inflammatory potential, but extra virgin olive oil remains the most evidence-backed oil for daily use.
Virgin vs. refined
Virgin (unrefined) coconut oil is cold-pressed from fresh coconut meat, retaining polyphenols, vitamin E, and the characteristic coconut aroma. It has a smoke point of ~177°C (350°F).
Refined coconut oil is processed from dried coconut (copra), typically bleached and deodorized. It has a higher smoke point (~204°C / 400°F) and neutral flavor, making it better for high-heat cooking. However, the refining process removes most polyphenols and antioxidants. Some refined coconut oils use chemical solvents (hexane) in processing — look for "expeller-pressed" refined coconut oil to avoid this.
For health purposes, virgin coconut oil is superior due to its retained polyphenols. For high-heat cooking where you need stability without coconut flavor, expeller-pressed refined is the best compromise.
Cooking stability
Coconut oil's high saturated fat content makes it exceptionally stable at cooking temperatures — saturated fats resist oxidation far better than polyunsaturated fats. This is why coconut oil doesn't produce harmful lipid peroxidation products (aldehydes, MDA) at the same rate as seed oils when heated. For stovetop cooking at moderate-to-high heat, coconut oil is one of the more stable options alongside ghee and tallow.
Evidence Review
Coconut Oil and Abdominal Obesity (2009 — PMID 25636220)
Assunção et al. randomized 40 women aged 20–40 with waist circumference >88 cm to receive either 30 ml/day of coconut oil or 30 ml/day of soybean oil for 12 weeks, alongside a controlled hypocaloric diet and daily walking [1]. Both groups reduced BMI and waist circumference comparably, but only the coconut oil group showed a significant increase in HDL cholesterol (P = 0.01). The soybean oil group showed increased total cholesterol and LDL, with decreased HDL — resulting in a significantly worse LDL/HDL ratio compared to the coconut oil group. Neither group showed increased triglycerides. Limitations include the small sample size (n = 40), the specific population studied (young women with abdominal obesity in Brazil), and the relatively short duration. Despite these caveats, the lipid profile findings are consistent with other studies showing coconut oil's preferential effect on HDL.
Lauric Acid Biochemistry (2015 — PMID 27213821)
Dayrit reviewed the metabolic fate and biological activity of lauric acid, clarifying its classification as a medium-chain fatty acid (C12) while noting its hybrid absorption behavior [2]. The paper documented that 70–75% of lauric acid is absorbed directly via the portal vein (MCT pathway), while 25–30% is packaged into chylomicrons (LCT pathway). This distinguishes it from shorter MCTs like caprylic (C8) and capric (C10) acid, which are almost entirely portal-absorbed. Dayrit also reviewed lauric acid's conversion to monolaurin and its downstream antimicrobial activity, noting that monolaurin disrupts lipid bilayer membranes through insertion into the fatty acid layer, causing membrane destabilization and cell lysis in susceptible microorganisms. The review is frequently cited in debates about whether lauric acid should be classified as a "true" MCT.
Antifungal Activity of Coconut Oil (2007 — PMID 12634436)
Ogbolu et al. tested coconut oil against 52 isolates of Candida species obtained from clinical specimens at the University College Hospital, Ibadan, Nigeria [3]. Coconut oil demonstrated 100% susceptibility against Candida albicans at full concentration, with a minimum inhibitory concentration (MIC) comparable to fluconazole for several isolates. Candida krusei showed the highest resistance but was still susceptible at higher concentrations. The proposed mechanism is monolaurin-mediated disruption of the fungal cell membrane. While these are in vitro results at concentrations higher than typical dietary intake would deliver systemically, the findings support topical and oral cavity applications (such as oil pulling) where direct contact between coconut oil and microorganisms occurs at relevant concentrations.
Cardiovascular Risk Review (2016 — PMID 28620111)
Eyres et al. conducted a systematic review of clinical trials and observational studies examining coconut oil's effects on cardiovascular risk factors [4]. The review identified 8 clinical trials and 13 observational studies. Consistent findings across trials: coconut oil raised total cholesterol and LDL more than unsaturated plant oils (olive, safflower, sunflower) but less than butter. Coconut oil consistently raised HDL more than comparison oils, often resulting in an improved or unchanged total cholesterol/HDL ratio. The authors concluded that the evidence does not support claims that coconut oil is "heart-healthy" in the way olive oil is, but neither does it support equating coconut oil with butter or animal fats for cardiovascular risk. They noted the absence of any large-scale epidemiological study directly linking coconut oil consumption to increased cardiovascular events. The AHA's 2017 advisory, published after this review, took a more cautionary stance — recommending against coconut oil based on its LDL-raising effect, though this remains debated among lipid researchers who prioritize the HDL response and particle size distribution.
References
- Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesityAssunção ML, Ferreira HS, dos Santos AF, Cabral CR Jr, Florêncio TM. Lipids, 2009. PubMed 25636220 →
- Lauric acid is a medium-chain fatty acid, mammalian target of rapamycin (mTOR) activator, and stimulates skeletal muscle protein synthesisDayrit FM. Journal of the American Oil Chemists' Society, 2015. PubMed 27213821 →
- In vitro antimicrobial properties of coconut oil on Candida species in Ibadan, NigeriaOgbolu DO, Oni AA, Daini OA, Oloko AP. Journal of Medicinal Food, 2007. PubMed 12634436 →
- Coconut oil consumption and cardiovascular risk factors in humansEyres L, Eyres MF, Chisholm A, Brown RC. Nutrition Reviews, 2016. PubMed 28620111 →
Transparency
View edit historyEvery change to this page is tracked in version control. If you have conflicting research or think something is wrong, we want to hear about it.